(Q46165673)

20 December 2017

MDMA

0 references

title

MDMA: on the translation from rodent to human dosing (English)

1 reference

20 December 2017

author

Johan Gabrielsson

2

1 reference

20 December 2017

author name string

A Richard Green

1

1 reference

20 December 2017

Charles A Marsden

3

1 reference

20 December 2017

Kevin C F Fone

4

1 reference

20 December 2017

publication date

13 January 2009

1 reference

20 December 2017

published in

Psychopharmacology

1 reference

20 December 2017

volume

204

1 reference

20 December 2017

page(s)

375-378

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-008-1453-8

exact match

0 references

cites work

The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1453-8

High performance liquid chromatographic assays of the illicit designer drug "Ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding

21 January 2018

1 reference

12 December 2020

Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans

1 reference

12 December 2020

Reply to letter by Green, Marsden and Fone (2007) about Sessa and Nutt's editorial (MDMA: baby with the bath water) in the November 2007 journal

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

12 December 2020

Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat

1 reference

12 December 2020

Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.

1 reference

12 December 2020

MDMA, politics and medical research: have we thrown the baby out with the bathwater?

1 reference

12 December 2020

Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

1 reference

12 December 2020

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

1 reference

12 December 2020

Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.

1 reference

12 December 2020

Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA.

1 reference

12 December 2020

Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").

1 reference

12 December 2020

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

12 December 2020

MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt.

1 reference

12 December 2020

1 reference

12 December 2020

Prenatal stress affects 3,4-methylenedioxymethamphetamine pharmacokinetics and drug-induced motor alterations in adolescent female rats.

1 reference

12 December 2020

A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates.

1 reference

12 December 2020

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

1 reference

12 December 2020

Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.

1 reference

12 December 2020

The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans

1 reference

12 December 2020

Retracted article on dopaminergic neurotoxicity of MDMA

1 reference

12 December 2020

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition

1 reference

12 December 2020

Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA

1 reference

12 December 2020

Caveat emptor: editors beware

1 reference

12 December 2020

Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain

1 reference

12 December 2020

The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity.

1 reference

12 December 2020

Ecstasy: are animal data consistent between species and can they translate to humans?

1 reference

12 December 2020

10.1007/S00213-008-1453-8

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19139850

1 reference

20 December 2017